trial

Social Cognitive Assessment in Autism and Schizophrenia

NCTId NCT02660775
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 440 (actual)
Sponsored by Hôpital le Vinatier
Primary completion 2021-03-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
440 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2015-12-04
Primary completion
2021-03-31
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
schizophreniaAutism

Sponsors

Hôpital le VinatierLead Sponsor

Investigators

1
Franck Nicolas, PUPHPrincipal Investigator

Sites

1 total
Bron, France

Facts & assertions

4 sourced
Enrollment
440
Phase
NA
Primary Completion Date
2021-03-31
Status
COMPLETED
relationships
The graph out of here
drug
schizophrenia
drug
Autism
drug
lead_sponsor
Hôpital le Vinatier
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Franck Nicolas, PUPH
person